Tus kws kho mob
P31-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective September 3, 2018
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 02, 2018
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2571 - 2580 ntawm 4205
Tus kws kho mob
P80-17 New Drug-Related PA with QL Criteria: Bonjesta, Diclegis
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 12, 2017
Tus kws kho mob
P67-18 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Medical Policies
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P47-18 New Medical Drug-Related Prior Authorization Requirements for Takhzyro (Lanadelumab-flyo)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P81-17 New Drug-Related PA Criteria: Opioid Induced Constipation (OIC)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 12, 2017
Tus kws kho mob
P35-18 Update: Change to TPA Business
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P65-17 Clarification to Commercial Prior Authorization for Biologic Immunomodulators
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 06, 2017
Tus kws kho mob
P39R1-18 Update: Blue Cross Contracts with eviCore to Expand Utilization Management for Post-Acute Care
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P2-18 New Medical Drug PA Requirements for Voretigene Neparvovec (Luxturna)
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 11, 2018
Tus kws kho mob
P11-18 Minnesota Health Care Programs (MHCP) Reimbursement Rate for Vaccine Administration
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 02, 2018